Pharmacodynamic Model To Describe the Concentration-Dependent Selection of Cefotaxime-ResistantEscherichia coli
Open Access
- 1 December 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (12) , 5081-5091
- https://doi.org/10.1128/aac.49.12.5081-5091.2005
Abstract
Antibiotic dosing regimens may vary in their capacity to select mutants. Our hypothesis was that selection of a more resistant bacterial subpopulation would increase with the time within a selective window (SW), i.e., when drug concentrations fall between the MICs of two strains. An in vitro kinetic model was used to study the selection of two Escherichia coli strains with different susceptibilities to cefotaxime. The bacterial mixtures were exposed to cefotaxime for 24 h and SWs of 1, 2, 4, 8, and 12 h. A mathematical model was developed that described the selection of preexisting and newborn mutants and the post-MIC effect (PME) as functions of pharmacokinetic parameters. Our main conclusions were as follows: (i) the selection between preexisting mutants increased with the time within the SW; (ii) the emergence and selection of newborn mutants increased with the time within the SW (with a short time, only 4% of the preexisting mutants were replaced by newborn mutants, compared to the longest times, where 100% were replaced); and (iii) PME increased with the area under the concentration-time curve (AUC) and was slightly more pronounced with a long elimination half-life (T1/2) than with a short T1/2 situation, when AUC is fixed. We showed that, in a dynamic competition between strains with different levels of resistance, the appearance of newborn high-level resistant mutants from the parental strains and the PME can strongly affect the outcome of the selection and that pharmacodynamic models can be used to predict the outcome of resistance development.Keywords
This publication has 44 references indexed in Scilit:
- Pharmacokinetic/Pharmacodynamic Modelling of Antibacterials In Vitro and In Vivo Using Bacterial Growth and Kill KineticsClinical Pharmacokinetics, 2005
- Pharmacodynamic Functions: a Multiparameter Approach to the Design of Antibiotic Treatment RegimensAntimicrobial Agents and Chemotherapy, 2004
- Suboptimal Antibiotic Dosage as a Risk Factor for Selection of Penicillin-Resistant Streptococcus pneumoniae : In Vitro Kinetic ModelAntimicrobial Agents and Chemotherapy, 2003
- Determination of Antibiotic Effect in an In Vitro Pharmacodynamic Model: Comparison with an Established Animal Model of InfectionAntimicrobial Agents and Chemotherapy, 2002
- Pharmacokinetic and Pharmacodynamic Parameters for Antimicrobial Effects of Cefotaxime and Amoxicillin in an In Vitro Kinetic ModelAntimicrobial Agents and Chemotherapy, 2001
- Persistent Acylation Of High-Molecular-Weight Penicillin-Binding Proteins By Penicillin Induces The Postantibiotic Effect In Streptococcus PyogmesThe Journal of Infectious Diseases, 1994
- Substitution of lysine at position 104 or 240 of TEM-1pTZ18R .beta.-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonamBiochemistry, 1991
- A Novel Chromosomal TEM Derivative and Alterations in Outer Membrane Proteins Together Mediate Selective Ceftazidime Resistance in Escherichia coliThe Journal of Infectious Diseases, 1990
- The post-antibiotic effect defined by bacterial morphologyJournal of Antimicrobial Chemotherapy, 1989
- Resource-Limited Growth, Competition, and Predation: A Model and Experimental Studies with Bacteria and BacteriophageThe American Naturalist, 1977